Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse

Updated on: March 30,2024

Advancing neuropathology with AI-driven classification of diffuse gliomas

by Liu Jia,Chinese Academy of SciencesTen examples of classification results on the external testing sets. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-41195-9Diffuse

Updated on:March 30,2024

Government housing assistance may boost some cancer screening

Updated on: April 14,2024

Government housing assistance may boost some cancer screening

Updated on:April 14,2024

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Updated on: February 18,2024

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Updated on:February 18,2024

How immune cells detect and respond to mutations in cancer cells

byUniversity of California, Los AngelesScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDFor the first time, a r

Updated on: January 02,2024

How immune cells detect and respond to mutations in cancer cells

byUniversity of California, Los AngelesScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDFor the first time, a r

Updated on:January 02,2024

From eye drops to potential leukaemia treatment

by Wellcome Trust Sanger InstituteA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaAn active ingredient

Updated on: March 12,2024

From eye drops to potential leukaemia treatment

by Wellcome Trust Sanger InstituteA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaAn active ingredient

Updated on:March 12,2024

Proton radiotherapy treats esophageal cancer for first time in Switzerland

by Paul Scherrer InstituteGantry 3 at the Center for Proton Therapy at PSI. With the help of this rotating treatment apparatus, cancer patients are irradiated with protons to destroy tumours. Cre

Updated on: February 03,2024

Proton radiotherapy treats esophageal cancer for first time in Switzerland

by Paul Scherrer InstituteGantry 3 at the Center for Proton Therapy at PSI. With the help of this rotating treatment apparatus, cancer patients are irradiated with protons to destroy tumours. Cre

Updated on:February 03,2024

Breast cancer survivors experience faster biological aging compared to cancer-free women, study finds

byH. Lee Moffitt Cancer Center & Research InstituteCase-control analysis of biological aging and breast cancer status. Results from multivariable linear regression models treating the biolog

Updated on: January 23,2024

Breast cancer survivors experience faster biological aging compared to cancer-free women, study finds

byH. Lee Moffitt Cancer Center & Research InstituteCase-control analysis of biological aging and breast cancer status. Results from multivariable linear regression models treating the biolog

Updated on:January 23,2024

Some breast cancer treatments may limit effectiveness of weight loss medications

by The Endocrine SocietyCredit: Unsplash/CC0 Public DomainBreast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presen

Updated on: February 03,2024

Some breast cancer treatments may limit effectiveness of weight loss medications

by The Endocrine SocietyCredit: Unsplash/CC0 Public DomainBreast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presen

Updated on:February 03,2024

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Updated on: February 20,2024

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Updated on:February 20,2024

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

Updated on: May 09,2024

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

Updated on:May 09,2024

Overall burden of tumor genome changes can predict patient outcomes

by eLifeKiller T cells surround a cancer cell. Credit: NIHResearchers have discovered a link between certain changes in the genome of a tumor and increased chances of death across multiple types

Updated on: April 09,2024

Overall burden of tumor genome changes can predict patient outcomes

by eLifeKiller T cells surround a cancer cell. Credit: NIHResearchers have discovered a link between certain changes in the genome of a tumor and increased chances of death across multiple types

Updated on:April 09,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on: January 30,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on:January 30,2024